biperiden has been researched along with Brain Disorders in 1 studies
Biperiden: A muscarinic antagonist that has effects in both the central and peripheral nervous systems. It has been used in the treatment of arteriosclerotic, idiopathic, and postencephalitic parkinsonism. It has also been used to alleviate extrapyramidal symptoms induced by phenothiazine derivatives and reserpine.
biperiden : A member of the class of piperidines that is N-propylpiperidine in which the methyl hydrogens have been replaced by hydroxy, phenyl, and 5-norbornen-2-yl groups. A muscarinic antagonist affecting both the central and peripheral nervous systems, it is used in the treatment of all forms of Parkinson's disease.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Seventeen patients initially were treated with trihexyphenidyl in dosage 10 mg daily with switching to biperiden after 3 months." | 2.78 | [The use of biperiden (akineton) in patients with ephedrone encephalopathy]. ( Datieva, VK; Levin, OS, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Levin, OS | 1 |
| Datieva, VK | 1 |
1 trial available for biperiden and Brain Disorders
| Article | Year |
|---|---|
[The use of biperiden (akineton) in patients with ephedrone encephalopathy].
Topics: Biperiden; Brain Diseases; Cross-Over Studies; Dose-Response Relationship, Drug; Female; Follow-Up S | 2013 |